Skip to main content
Premium Trial:

Request an Annual Quote

Verisante Raises $310,000 in Private Placement

Premium

Verisante Technology said it has raised C$350,000 ($310,000) in a non-brokered private placement.

The placement, from unidentified Chinese investors, consisted of 2.5 million common shares at a price of C$.14 per share.

With this placement, the Chinese group has now invested C$650,000 of the C$2.15 million they have agreed to put into Verisante over the next 24 months as per an agreement between the two parties.

The money will be used for working capital requirements, Verisante said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more